Treace Medical Concepts reported a smaller-than-expected adjusted loss of $0.19 per share for Q3 2026, beating the estimated loss of $0.25 per share. Revenue was $48.25 million, slightly above estimates but down from the previous year. The company improved its financial health with a 23% reduction in net loss and positive adjusted EBITDA, though it remains unprofitable. Cash usage fell 53% year-to-date, and the company holds nearly $40 million in cash and equivalents, indicating better liquidity despite continued losses.
Treace Medical Concepts reported a smaller-than-expected adjusted loss of $0.19 per share for Q3 2026, beating estimates. For readers following the health sector, here is Pluang's market snapshot as of Nov 07, 2026 11:41 WIB: out of 150 priced US health stocks, 88 rose and 62 fell. Notable movers include DFTX at USD 33.27 (+9.58%), RLAY at USD 18.60 (+9.41%), and ELAN at USD 25.74 (+8.75%).
AirSculpt Technologies reported a disappointing Q3 2026 with a loss of $0.10 per share, wider than the expected $0.03 loss, and revenue of $31.9 million, below the estimated $34.3 million. The company faced weaker marketing returns, operational issue...
Binance revealed that attackers stole $6.34 billion by compromising employee devices, but the exchange will cover all customer losses. Meanwhile, US spot Bitcoin ETFs experienced $430.2 million in net outflows on November 5, continuing a trend of wit...
Pepe (PEPE) token price fell 2.61% to $0.000004719 with trading volume increasing 17.01% to about $388.3 million. The price fluctuated between $0.00000460 and $0.00000485, with $0.00000460 acting as support and $0.00000480-$0.00000485 as resistance. ...
Investor Yiannis Zourmpanos is aggressively accumulating Nebius shares following a 55% price correction, seeing it as a strong buying opportunity. Consensus forecasts Nebius to report $905.74 million in Q3 revenue, but achieving the annual target of ...
A crypto enthusiast projected a hypothetical XRP price of $254, based on a historical percentage gain similar to XRP's 2014-2018 rally. This would imply a fully diluted market valuation of about $25.4 trillion, assuming the token's maximum supply of ...
